Reply to the Vioxx debacle

Am J Med. 2006 Jan;119(1):93-4. doi: 10.1016/j.amjmed.2005.06.069.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Carbonic Anhydrase Inhibitors / adverse effects*
  • Carbonic Anhydrase Inhibitors / chemistry
  • Carbonic Anhydrase Inhibitors / pharmacology
  • Cyclooxygenase 2 Inhibitors / adverse effects*
  • Cyclooxygenase 2 Inhibitors / chemistry
  • Cyclooxygenase 2 Inhibitors / pharmacology
  • Humans
  • Lactones / adverse effects*
  • Lactones / chemistry
  • Lactones / pharmacology
  • Structure-Activity Relationship
  • Sulfones / adverse effects*
  • Sulfones / chemistry
  • Sulfones / pharmacology

Substances

  • Carbonic Anhydrase Inhibitors
  • Cyclooxygenase 2 Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib